We are excited to launch our brand-new virtual event, 60 Miles in September! Sign up today to complete 60 miles during the month of September – you can do it by walking, running, cycling, you could ...

Run 13.1 unforgettable miles through Cambridge’s historic streets and iconic University grounds on a flat, fast-paced course perfect for chasing personal bests or enjoying your first half marathon.

Epilepsy awareness & seizure management training, 1st July3-hour online course (via Teams) providing delegates with an understanding of epilepsy and how to manage different types of seizures. CPD ...

Living with epilepsy can be challenging, not just for those diagnosed but also for their family and friends. Understanding more about epilepsy and how to offer effective support can make a significant ...

Epilepsy awareness & seizure management training, 1st July6-hour live online course (via Teams) providing delegates with an understanding of epilepsy, how to manage different types of seizures, and ...

Epilepsy awareness & seizure management training, 25th Septemberan introduction to epilepsy causes and diagnosis types of seizures (including management and first aid) status epilepticus treatments – ...

As part of our medications shortages campaign, our CEO Clare Pelham was interviewed on BBC Look North, alongside the mother of 44-year-old David Crompton who tragically died last December after being ...

20 May marks the start of National Epilepsy Week 2024. But it is also 100 days to the start of the Paralympics in Paris, when elite athletes from across the globe will be going for gold in their ...

Updated safety and educational materials have been published for the anti-seizure medication valproate*. You should never stop taking valproate without first consulting your doctor. The updates ...

Many people with epilepsy and their friends, family and carers find social media a great way to connect with others, find information and share experiences. With this in mind, we have outlined below ...

A late-stage study has shown promising results for the effectiveness of fenfluramine in people with an ultra-rare form of epilepsy - CDKL5 deficiency disorder (CDD). CDD affects approximately one in ...